Year: 2020

PHILADELPHIA, Nov. 11, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today commends the newly published research of the University of Pennsylvania’s (Penn) Gene Therapy Program (GTP) regarding a novel targeted approach to prevent a selective neurotoxicity seen in the sensory neurons of dorsal root ganglia (DRG) after gene therapy treatment. As previously published, this DRG toxicity has been observed after both systemic and central nervous system (CNS) delivery of gene therapy and across a variety of vectors in pre-clinical models, but clinical manifestations have not been observed.1As part of its unique collaboration agreement with Penn, Passage Bio has certain rights to this novel DRG...

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that John F. Thero, Amarin’s president and chief executive officer, is scheduled to present general company updates at the following investor conferences scheduled in November:Stifel 2020 Virtual Healthcare conference on Monday, November 16, 2020 at 8:40 a.m. Eastern Time (ET)Jefferies Virtual London Healthcare conference on Thursday, November 19, 2020 at 9:40 a.m. Eastern Time (ET)Live audio webcasts of the presentations will be available at: http://www.amarincorp.com, and will be accessible at the same link for 30 days.About AmarinAmarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular...

TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce its financial results for the quarter ended September 30, 2020.The Company’s unaudited condensed and consolidated interim financial results for the quarter ended September 30, 2020, together with its Management’s Discussion and Analysis (“MD&A”) for the corresponding period, can be accessed under the Company’s profile on www.sedar.com and on the Company’s website at www.mandalayresources.com. All currency references in this press release are in U.S. dollars except as otherwise indicated.Third Quarter 2020 Highlights:Quarterly revenue of $49.8 million, highest since Q2 2016;Adjusted EBITDA of $26.7 million, the second highest in Company history;Free cash...

BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET.LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon Additional information can be found at www.lemaitre.com.

TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Global Atomic Corporation (“Global Atomic” or the “Company”), (TSX: GLO, FRANKFURT: G12, OTCQX: GLATF) announced today its operating and financial results for the three and nine months ended September 30, 2020.HIGHLIGHTS

HOUSTON, Nov. 11, 2020 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today that it plans to issue its third quarter 2020 earnings release after market close on Monday, November 16, 2020. In conjunction with the release, Contango will conduct a conference call to discuss the contents of that release on Monday, November 16, 2020 at 5:00 pm Central Standard Time.Teleconference CallThose interested in participating in the earnings conference call may do so by clicking here to join and entering your information to be connected. The link becomes active 15 minutes prior to the scheduled start time, and the conference coordinator will call you. If you are not at a computer, you can join by dialing 800-309-1256, (International 1-323-347-3622) and entering participation code...

NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant industrial real estate investments, today announced that it sold its interest in the Lake Jackson, Texas office property leased to Dow Chemical for $192 million, including the assumption by the buyer of the first mortgage loan secured by the property, which had an unpaid principal balance of $179 million. In connection with the sale, Lexington anticipates it will recognize a $57 million gain on the sale.In addition, Lexington acquired a 201,784 square foot warehouse/distribution facility on 48 acres in a logistics submarket of Phoenix, Arizona for $88 million. The facility is 100% leased to a leading e-commerce company through March 2033.ABOUT LEXINGTON REALTY TRUSTLexington Realty...

DENVER, Nov. 11, 2020 (GLOBE NEWSWIRE) — ANGI Homeservices (NASDAQ: ANGI) will attend the Needham Virtual Internet Services Conference on Monday, November 16, 2020.  Brandon Ridenour, Chief Executive Officer of ANGI Homeservices, will participate in a fireside chat at 10:00 a.m. ET.  A live webcast of this virtual fireside chat will be available to the public on Needham’s website and a replay of the webcast will be available at http://ir.angihomeservices.com/ and http://www.iac.com/Investors/.  About ANGI Homeservices Inc.ANGI Homeservices Inc. (NASDAQ: ANGI) turns home improvement jobs imagined into jobs well-done. People throughout North America and Europe rely on us to book quality home service pros across 500 different categories, from repairing and remodeling to cleaning and landscaping. Over 230,000 domestic service professionals...

Submitted a premarket approval (PMA) to the FDA for LungFit™ PH to treat persistent pulmonary hypertension of the newborn (PPHN)Expect patient enrollment to begin next week for the acute viral pneumonia (including SARS-CoV-2) study; Patients will be treated with 150 ppm nitric oxide with LungFit™ PROLungFit™ GO nontuberculous mycobacteria (NTM) lung infection at-home pilot study expected to start in December 2020Conference call scheduled for today, November 11that 4:30 pm ETGARDEN CITY, N.Y., Nov. 11, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid...

WESTLAKE VILLAGE, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Frank Watanabe, President and CEO, will present a corporate overview during the Stifel 2020 Virtual Healthcare Conference taking place November 16-18, 2020.Details for the presentation are as follows:        Stifel 2020 Virtual Healthcare Conference        Presentation Date: Wednesday, November 18, 2020        Presentation Time: 12:20 p.m. PST / 3:20 p.m. ESTThe presentation will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at https://investors.arcutis.com/events-and-presentations....